Compounding pharmacy Empower Pharmacy and outsourcing facility Empower Pharma announced on Tuesday the appointment of Bob Irwin as president.
Irwin has more than a decade of executive leadership experience and has served as CEO at five successful ventures. Most recently, he was a CEO Advisor at Korn Ferry.
With this appointment, founder Shaun Noorian will transition to the role of CEO and chairman of the network enterprise.
Noorian said: "Bob Irwin's impressive track record in scaling businesses while fostering a strong internal culture makes him the perfect fit for Empower as we enter this exciting new phase of growth. His leadership experience and success in driving business performance align seamlessly with our strategic objectives."
SIFI enters scientific collaboration with UCSF on Acanthamoeba Keratitis
Johnson & Johnson's nipocalimab granted FTD for treatment of Sjogren's disease
Vascarta launches phase I VAS101 clinical study in osteoarthritis
GRIN Therapeutics' Radiprodil receives Orphan Drug designation
BioArctic receives US FDA orphan drug designation OOPD for exidavnemab
Physiomics secures GBP102,000 contract with UK biotech for ADC therapy development
Revelation Biosciences reports Gemini's anti-inflammatory potential in PBMC study
Eneboparatide Shows Positive Results in Phase III Trial for Chronic Hypoparathyroidism
Precision BioSciences secures IND clearance for gene editing therapy targeting chronic hepatitis B
Biophytis advances sarcopenia treatment with positive Phase 2 results
AstraZeneca secures EU approval for Imfinzi in limited-stage small cell lung cancer
BioSurfaces collaborates with Morphocell Technologies
iOncologi acquires TargImmune Therapeutics
Argent BioPharma announces positive CimetrA Phase IIb clinical trial results